Ikena Oncology to effect 1-for-12 reverse stock split, rename to ImageneBio, ticker IMA

ImageneBio, Inc.

1-for-12 reverse stock split effective July 28, 2025; shares outstanding drop from ~48.2M to ~4M.
Company will rename ImageneBio, Inc., trade under ticker "IMA" on Nasdaq, new CUSIP 45175G207.
No fractional shares; cash paid based on July 24 closing price multiplied by fractional share.
Exercise prices and shares underlying equity awards will be proportionally adjusted; par value unchanged.
Stockholders in book-entry or brokerage accounts need no action; beneficial holders contact broker.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.